Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
05 Jul 2018 Comparison of Available Treatment Strategies and Chemotherapeutic Options for Locally Advanced Head and Neck Cancer Head and neck cancers - Anticancer agents & Biologic therapy
04 Jul 2018 EMA Recommends Extension of Indications for Lenvatinib Gastrointestinal cancers - Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
02 Jul 2018 EMA Recommends Extension of Indications for Nivolumab Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
02 Jul 2018 EMA Recommends Granting a Marketing Authorisation for Neratinib After Re-examining Its Negative Opinion for This Medicine Breast cancer - Anticancer agents & Biologic therapy
28 Jun 2018 Survivors of Childhood Extracranial Malignancy Who Received Chemotherapy Are Likely to Have Long-Term Neurological Toxicity Cancer in Special Situations
28 Jun 2018 FDA Approves Encorafenib and Binimetinib in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations Melanoma and other skin tumours - Personalised medicine - Anticancer agents & Biologic therapy
27 Jun 2018 FDA Approves Avatrombopag for Thrombocytopenia in Adults with Chronic Liver Disease Gastrointestinal cancers - Palliative and supportive care
26 Jun 2018 ESMO World GI Congress 2018: IMblaze370 study Did Not Meet Its Primary Endpoint Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
26 Jun 2018 ESMO World GI Congress 2018: Trifluridine/Tipiracil Effective in Patients with Heavily Pretreated Metastatic Gastric Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
25 Jun 2018 IMpower133 Study Met Co-primary Endpoints at First Interim Analysis Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
21 Jun 2018 Clinical Benefit Associated with Participation in Modern Phase I Oncology Studies Anticancer agents & Biologic therapy
20 Jun 2018 ASCO 2018: Large Study of DNA Mismatch Repair Genes Determines Mutation Frequency in Several Types of Cancer Pathology/Molecular biology - Epidemiology/Etiology/Cancer Prevention
19 Jun 2018 FDA Approves Pembrolizumab for Treatment of Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy
18 Jun 2018 FDA Approves Bevacizumab in Combination with Chemotherapy for Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
15 Jun 2018 FDA Approves Pembrolizumab for Advanced Cervical Cancer with Disease Progression During or After Chemotherapy Gynaecologic malignancies - Cancer Immunology and Immunotherapy